Pediatric Cardiology and Cardiac Surgery
Online ISSN : 2187-2988
Print ISSN : 0911-1794
ISSN-L : 0911-1794
Review
Drug Therapy in Adult Congenital Heart Disease with Heart Failure
Ichiro Sakamoto
Author information
JOURNAL FREE ACCESS

2022 Volume 38 Issue 4 Pages 221-228

Details
Abstract

Currently, most patients with congenital heart disease (CHD) reach adulthood, and heart failure (HF) is one of the leading causes of death for adult patients with CHD. Therefore, an appropriate treatment strategy for HF is essential for improving their prognosis. Medical therapy for HF is as crucial as surgical or catheter-related therapy. Recently, novel agents for treating HF have emerged that have dramatically changed the strategy for HF therapy. Thus, updating knowledge of these therapeutic agents, both standard and novel, is vital. Hopefully, this article will be helpful in daily practice.

Content from these authors
© 2022 Japanese Society of Pediatric Cardiology and Cardiac Surgery
Previous article Next article
feedback
Top